Results 61 to 70 of about 141,910 (361)

Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic regurgitation [PDF]

, 2014
ObjectivesThe durability of valve-sparing aortic root procedures with aortic regurgitation due to leaflet disease is questioned. Here, we review our experience in combined aortic root and valve reconstruction in children and young adults.MethodsAll valve-
Baird, Christopher W., del Nido, Pedro J., Emani, Sitaram M., Marx, Gerald R., Myers, Patrick O.   +4 more
core   +2 more sources

Advanced Microfluidics for Single Cell‐Based Cancer Research

Advanced Science, EarlyView.
Cutting‐edge microfluidic platforms are transforming single‐cell cancer research. This review highlights advanced technologies, from droplet microfluidics to tumour‐chips, that enable functional and spatial single‐cell analyses. By integrating biosensing, immune components, and patient‐derived materials, these systems offer new insights into tumour ...
Adriana Carneiro, Marta Aranda Palomer, Margarida Esteves, Carolina Rodrigues, José Maria Fernandes, Francisca Oliveira, Alexandra Teixeira, Carlos Honrado, Lorena Dieguez, Sara Abalde‐Cela, Miguel Xavier   +10 more
wiley   +1 more source

Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve

Journal of Indian College of Cardiology, 2021
Abstract Transcatheter aortic valve replacement (TAVR) is being routinely done in various centres for aortic stenosis due to tricuspid aortic valves. The number of TAVR procedures are increasing, but the data on bicuspid aortic valves (BAV) is scanty. BAV is commonest abnormality in general population and can progress to severe
Immaneni Sathyamurthy, Sai Satish
openaire   +3 more sources

A Human Engineered Heart Tissue‐Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin

Advanced Science, EarlyView.
This study develops a human engineered heart tissue‐derived model of diabetic cardiomyopathy that accurately replicates the dynamic changes in the structural, contractile, and electrophysiological properties of the myocardium. Furthermore, this model is used to confirm the direct protective effects of empagliflozin on the heart through an SGLT2 off ...
Lin Cai, Yuxin Zhao, Zilong Li, Liping Xiao, Yifan Wu, Shiya Wang, Qian Liu, Yida Ye, Yuxuan Guo, Donghui Zhang   +9 more
wiley   +1 more source

Double cardiac pseudoaneurysm in a postoperative patient

Türk Kardiyoloji Derneği Arşivi, 2015
A mitral-aortic intervalvular fibrosa pseudoaneurysm is a rare complication after aortic and mitral valve replacement and aortic root replacement. A left ventricular pseudoaneurysm after mitral valve replacement is also a rare complication.
Tahereh Davarpasand, Ali Hosseinsabet
doaj   +1 more source

Six year clinical study of use of the Omniscience valve prosthesis in 219 patients [PDF]

, 1987
A 6 year experience of cardiac valve replacement with the Omniscience prosthesis is described. A total of 253 valves were inserted in 219 patients. The survivors were followed up for a total of 536 patient-years and for a mean of 2.8 years. The follow-up
Callaghan, John C., Coles, John, Damle, Ajit   +2 more
core   +1 more source

Truncating Variants in RREB1 Cause a Novel RASopathy Syndrome of Congenital Heart Disease, Genitourinary Malformations, and Developmental Delay

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT The interstitial 6p microdeletion syndrome is characterized by dysmorphic facies and structural heart, kidney, brain, and musculoskeletal differences. RREB1 haploinsufficiency and consequent abnormal RAS‐MAPK pathway signaling have been proposed as a driver of the disease phenotype; however, apart from a single case report, the phenotype of ...
Alanna Strong, Caoimhe McKenna, Karen Stals, Antonio Vitobello, Mathilde Renaud, Claudine Rieubland, Michel Guipponi, Christophe Philippe, Paul Vrana, Alisa Gaskell, A. Micheil Innes, Alyssa L. Rippert, Rebecca Ahrens‐Nicklas, Elizabeth Bhoj, Kiersten Keller, Bimal P. Chaudhari, Brandon S. Stone   +16 more
wiley   +1 more source

Same-Day Discharge After Transcatheter Native Aortic and Mitral Valve-in-Valve Replacement

JACC: Case Reports, 2020
Transcatheter aortic valve replacement has become the gold standard of care in the management of patients with severe aortic stenosis and transcatheter mitral valve-in-valve replacement seems to be an attractive alternative to redo surgery. We report the
Vinayak Nagaraja, MBBS, MS MMed (Clin Epi), Amar Krishnaswamy, MD, James Yun, MD, Samir R. Kapadia, MD   +3 more
doaj  

All-cause procedural readmissions following transcatheter aortic valve replacementCentral MessagePerspective

JTCVS Open, 2023
Objective: With expanding eligibility criteria, transcatheter aortic valve replacement is being performed on patients with longer life expectancy, and subsequent procedures after index transcatheter aortic valve replacement are inevitable.
Paige Newell, MD, Hoda Javadikasgari, MD, Mehida Rojas-Alexandre, MD, Sameer Hirji, MD, MPH, Morgan Harloff, MD, Olena Cherkasky, MS, Siobhan McGurk, BS, Alexandra Malarczyk, BS, Pinak Shah, MD, Ashraf Sabe, MD, Tsuyoshi Kaneko, MD   +10 more
doaj  

Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body [PDF]

, 1997
Objective: The intervalvular fibrous body between the aortic and mitral valves can be damaged by infective endocarditis, degenerative calcification, or multiple previous heart valve operations, making double valve replacement difficult.
Armstrong, Susan, David, Tirone E., Kuo, James   +2 more
core   +1 more source